<DOC>
	<DOCNO>NCT01909999</DOCNO>
	<brief_summary>The aim study compare release osteoprotegerin ( OPG ) , transform growth factor ( TGF-α ) , osteocalcin ( OCN ) , osteopontin ( OPN ) , parathyroid hormone ( PTH ) osseointegration dental implant without immediate loading . Forty patient select randomly divide : Group IM - implant prosthesis placement within 72 hour ; Group NL - implant insertion prosthesis placement 120 day . Peri-implant crevicular fluid ( PICF ) collect immediately implant insertion 7 , 15 , 30 , 60 , 90 , 120 day surgery evaluated level OPG , TGF-α , OCN , OPN PTH use Luminex assay . Clinical aspect ( Sulcus bleed peri-implant probe depth ) also assess . The data compare use ANOVA/Tukey Friedman/Mann-Whitney test ( α=5 % ) .</brief_summary>
	<brief_title>Release Osteogenic Markers Immediately Non-loaded Dental Implants</brief_title>
	<detailed_description>This prospective , parallel control clinical-laboratory trial . The population evaluate study select Graduate Clinic Dental Implantology - UNIP-SP . The selected patient randomly allocate ( computer generate list ) : Group IM - ( n = 20 ) - patient receive placement implant prosthesis within period 3 day , characterize immediate loading implant protocol ; Group NL - ( n = 20 ) - patient receive single-stage dental implant placement dental prosthesis within period 4 month , characterize non-loading implant ; The surgery , well postoperative follow-up , perform dental clinic UNIP-SP . Surgical area anesthetize ( 2 % mepivacaine 1:100,000 epinephrine ) mucoperiosteal incision alveolar ridge mucosa make . The surgical sequence follow protocol describe implant company supplier implant ( SIN - São Paulo , SP , BR ) . In case , maxilla rehabilitation , 6 implant instal , , mandible , 5 use . Soft-tissue sutured simple interrupt suture use absorbable polygalactin 910 suture . Postoperative care : amoxicillin 500 mg ( 8-8 hours/7 day ) ; sodic dipyrone 500mg ( 6-6 hours/3 day ) ; 0.12 % Chlorhexidine mouthwash ( 12-12 hours/10 day ) . The patient IM Group receive Brånemark full arch prosthesis within 3 day implant . All prosthesis use straight mini-abutments ( SIN , São Paulo , SP ) receive occlusal adjustment monthly clinical monitoring ( include modify bleed probe peri-implant probe depth ) . Evaluation osteogenic marker The collection peri-implant crevicular fluid ( PICF ) perform immediately implant insertion ( Baseline ) 7 , 15 , 30 , 60 , 90 120 day . The site collect dried isolated sterile gauze . PICF collect four site per implant use absorbent paper strip ( Periopaper , Oralflow , Smithtown , New York ) . The volume fluid measure immediately aid Periotron ( Oraflow , Smithtown , New York ) condition 400uL PBS buffer + 0.05 % Tween frozen -80°C . The level peri-implant osteogenic marker ( OPG , OCN , OPN , TGF-α , PTH ) determine use LUMINEX/Magpix system ( HBN1A-51K HCCBP1MAG-58K , Millipore Corporation , Billerica , MA , USA ) . The sample analyze individually level estimate use 5-parameter polynomial curve Xponent® software ( Millipore Corporation , Billerica , MA ) . The concentration value express pg/ml . Statistical Analysis The null hypothesis consider study absence difference peri-implant osteogenic marker concentration different loading protocol . For data analysis , statistical program use ( SAS release 9.1 , 2003 , SAS Institute Inc. , Cary , NC , USA ) . The demographic clinical data compare group use Student 's t-test ( age ) , Fisher 's Exact test ( gender site implant ) . The data level osteogenic marker first analyze homogeneity use Shapiro-Wilk test , indicate non-normal distribution . Thus , nonparametric test - Friedman intragroup Mann-Whitney intergroup analysis , perform . All analysis consider α=5 % .</detailed_description>
	<mesh_term>Jaw , Edentulous</mesh_term>
	<criteria>patient mandibular and/or maxillary edentulous arch indicate rehabilitation dental implant extraction occur least 4 month prior treatment good oral hygiene ( plaque index &lt; 20 % ) ( Ainamo &amp; Bay , 1975 ) age 1865 year presence systemic disease ( include diabetes , arthritis , hypothyroidism , osteoporosis , etc ) use medication ( six month prior study ) contraindicate placement alter implant osseointegration use antiinflammatory three month surgery patient submit bone graft site select implant pregnant breastfeed woman smoker exsmokers</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Dental Implants</keyword>
	<keyword>Osseointegration</keyword>
	<keyword>Immediate Dental Implant Loading</keyword>
	<keyword>Bone formation</keyword>
</DOC>